THE EFFICACY AND SAFETY OF LEBRIKIZUMAB PLUS TOPICAL CORTICOSTEDOIDS IN MODERATETO SEVERE ATOPIC DERMATITIS. CDF 2024, 53 (03), 6987-6993. https://doi.org/10.48047/vwmbcr61.